Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1989-05-19
1990-10-23
Griffin, Ronald W.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 173, 536 174, 536 181, 536 182, 536 175, 514 27, C07H 1524, C07H 1520, C07H 1526
Patent
active
049653482
ABSTRACT:
The present invention provides novel dimers of epipodophyllotoxin glucosides wherein the two units are connected via a diacyl linker. These compounds have useful property as tumor inhibiting agents.
REFERENCES:
patent: 3524844 (1970-08-01), Keller-Juslen
patent: 4567253 (1986-01-01), Durst et al.
patent: 4716221 (1987-12-01), Umezawa et al.
patent: 4853467 (1989-08-01), Vyas et al.
patent: 4868291 (1989-09-01), Saulnier et al.
patent: 4874851 (1989-10-01), Vyas et al.
patent: 4888419 (1989-12-01), Saulnier et al.
patent: 4912204 (1990-03-01), Ohnuma et al.
patent: 4916217 (1990-04-01), Saulnier
Levy, R. K. et al., "Antitumor Agents LXII: Synthesis and Biological Evaluation of Podophyllotoxin Esters and Related Derivatives", J. Pharm. Sci., 1983, 72(10):1158-1161.
Wakelin, L. P. G.; "Polyfunctional DNA Intercalating Agents", Medicinal Res. Rev., 1986, 6(3):275-340.
Langley David R.
Saulnier Mark G.
Bristol-Myers Company
Carson Nancy S.
Griffin Ronald W.
Yang Mollie M.
LandOfFree
Dimeric epipodophyllotoxin glucoside derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dimeric epipodophyllotoxin glucoside derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimeric epipodophyllotoxin glucoside derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-767696